<DOC>
	<DOCNO>NCT02390726</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness Fecal Microbiota Transplant ( FMT ) treat patient mild moderate Ulcerative Colitis ( UC ) . Even expand choice medication UC , physicians patient still search highly effective safe medication minimal side effect . FMT approve treatment bacterial infection call Clostridium difficile . In set , FMT proven effective safe alternative therapy zero report serious adverse event patient treatment . The provider conduct study hypothesize deliver microbe healthy human gut help treat damage cause UC . This do `` transplant '' fecal material , contain highly complex dense community healthy microbe , include bacteria , fungi virus . This collection microbes refer microbiome . Preliminary study suggest alteration microbiome help treat UC .</brief_summary>
	<brief_title>Fecal Microbiota Transplant Treatment Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Men woman 1875 year age . Established diagnosis ulcerative colitis ( UC ) know involvement leave colon Mild moderate disease define endoscopic evidence disease Mayo endoscopic subscore 1 2 total MAYO score range 410 . ( The Mayo score range 0 12 , high score indicate severe disease . This score use initial evaluation monitoring treatment response ) . Patients may class IBDrelated medication ( exclude steroid ) Patients must stable medication regimen least 6 week prior enrollment . Ability understand willingness sign inform consent document Patient asymptomatic Patients severe , refractory disease ( defined Mayo score &gt; 10 , endoscopic disease activity score &gt; 3 ) patient significant condition , opinion investigator , could confound interfere evaluation safety , tolerability investigational treatment prevent compliance study protocol Prior colectomy Positive stool test following : Clostridium difficile PCR , Salmonella , Shigella , Yersinia , Campylobacter , enteropathogenic E. coli standard stool culture . Use steroid medication ( formulation ) prior 6 week enrollment Systemic antibiotic use within prior 6 week enrollment Regular probiotic supplement use within prior 48 hour enrollment Pregnancy breastfeed Severe immunodeficiency , inherit acquire ( e.g . HIV , chemotherapy , radiation therapy ) History anaphylaxis ( severe allergic reaction ) Documented allergy fluoroquinolones , metronidazole Life expectancy le 12 month Age le 18 great 75 year age History esophageal gastric motility disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>